Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany flag Germany · Delayed Price · Currency is EUR
453.95
+14.70 (3.35%)
Apr 1, 2025, 5:35 PM CET

Vertex Pharmaceuticals Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
115,184100,17194,85769,36149,09550,241
Upgrade
Market Cap Growth
5.60%5.60%36.76%41.28%-2.28%0.14%
Upgrade
Enterprise Value
106,41991,03983,20160,99043,74545,660
Upgrade
Last Close Price
453.95387.65371.20270.10197.14191.32
Upgrade
PE Ratio
--28.9722.3123.8422.66
Upgrade
PS Ratio
9.419.4110.628.307.379.90
Upgrade
PB Ratio
6.326.325.965.335.537.08
Upgrade
P/TBV Ratio
7.157.156.706.076.428.44
Upgrade
P/FCF Ratio
-31.4218.8923.1820.53
Upgrade
P/OCF Ratio
-29.6417.9521.1218.89
Upgrade
EV/Sales Ratio
10.448.559.327.306.579.00
Upgrade
EV/EBITDA Ratio
23.3819.7420.5414.4012.3817.66
Upgrade
EV/EBIT Ratio
25.0520.5221.3514.8912.7818.29
Upgrade
EV/FCF Ratio
-139.41-27.5616.6120.6618.66
Upgrade
Debt / Equity Ratio
0.110.110.050.070.100.11
Upgrade
Debt / EBITDA Ratio
0.360.360.180.200.240.30
Upgrade
Debt / FCF Ratio
--0.240.230.400.32
Upgrade
Asset Turnover
0.490.490.480.570.600.62
Upgrade
Inventory Turnover
5.145.147.388.878.9710.62
Upgrade
Quick Ratio
2.172.173.604.464.044.02
Upgrade
Current Ratio
2.692.693.994.834.464.33
Upgrade
Return on Equity (ROE)
-3.15%-3.15%22.99%27.67%24.93%36.71%
Upgrade
Return on Assets (ROA)
12.68%12.68%13.17%17.33%19.32%19.02%
Upgrade
Return on Capital (ROIC)
15.71%15.71%16.22%21.15%23.51%23.29%
Upgrade
Return on Capital Employed (ROCE)
24.20%24.20%22.50%28.40%34.50%30.90%
Upgrade
Earnings Yield
-0.45%-0.52%3.45%4.48%4.20%4.41%
Upgrade
FCF Yield
-0.66%-0.76%3.18%5.29%4.31%4.87%
Upgrade
Buyback Yield / Dilution
1.00%1.00%-0.54%0.31%1.33%-1.04%
Upgrade
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.